List of Oncology Medication For

Breast Cancer

The treatment of breast cancer depends on several factors, including the type and stage of the cancer, its size, location, and whether it has spread to other parts of the body. Treatment options may include: Surgery, Radiation therapy, Chemotherapy, Hormone therapy, Targeted therapy, Immunotherapy.

If Breast Cancer Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Gemcitabine for injection

Ovarian, Bile Duct Cancer, Breast Cancer, Lung Cancer, Pancreatic

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

IXEMPRA Kit (ixabepilone) for Injection

Breast Cancer

IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200

XEMPRA is a prescription medicine. IXEMPRA is used to treat breast cancer. • IXEMPRA, a microtubule inhibitor, in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane. • IXEMPRA as monotherapy is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline, a taxane and capecitabine. .

Brand Name:	IXEMPRA Kit
Generic Name:	ixabepilone
Strength:	• IXEMPRA for injection, 15 mg supplied with DILUENT for IXEMPRA, 8 mL • IXEMPRA for injection, 45 mg supplied with DILUENT for IXEMPRA, 23.5 mL
Manufacturer:	R-Pharm
Approved By:	EMA, USFDA

Source content : www.accessdata.fda.gov

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection” based on the information you provide.

LYNPARZA (olaparib) tablets

Breast Cancer, Ovarian, Pancreatic, Prostate

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

It targets specific enzymes within cancer cells and stops the cancer cell from growing. This medicine is used to treat certain kinds of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.

Brand Name:	LYNPARZA
Generic Name:	olaparib
Strength:	• Tablets: 150 mg, 100 mg
Manufacturer:	AstraZeneca
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “LYNPARZA (olaparib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for LYNPARZA (olaparib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

margetuximab-cmkb injection

Breast Cancer

margetuximab-cmkb injection
for intravenous use Initial U.S. approval: 2020

Margenza (margetuximab-cmkb) is a medication used in combination with chemotherapy, to treat adults with metastatic HER2-positive breast cancer after at least two previous rounds of therapy.

Facts about margetuximab-cmkb injection

Disease Indications-Breast Cancer
Manufacturer-MacroGenics
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “margetuximab-cmkb injection” based on the information you provide.

Neratinib Tablets

Breast Cancer

neratinib tablets,
for oral use Initial U.S. Approval: 2017

Nerlynx (neratinib) is a medication indicated for the adjuvant treatment of adult patients with early-stage HER2 positive overexpressed/amplified breast cancer.

Facts about neratinib tablets

Disease Indications-Breast Cancer
Manufacturer-Puma biotechnology
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA) Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Neratinib Tablets” based on the information you provide.

NERLYNX (neratinib) tablets

Breast Cancer

NERLYNX (neratinib) tablets, for oral use Initial U.S. Approval: 2017

NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.

Brand Name:	NERLYNX
Generic Name:	neratinib
Strength:	• Tablets: 40 mg.
Manufacturer:	Puma Biotechnology, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection” based on the information you provide.

ORSERDU (elacestrant) tablets

Breast Cancer

Brand Name: ORSERDU. Generic Name: elacestrant). It is used to treat advanced or metastatic breast cancer.

Orserdu is a cancer medicine used to treat postmenopausal women and men with breast cancer that is locally advanced or metastatic (has spread to other parts of the body).

Brand Name:	ORSERDU
Generic Name:	elacestrant
Strength:	• Tablets: 345 mg and 86 mg
Manufacturer:	Stemline Therapeutics, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “ORSERDU (elacestrant) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for ORSERDU (elacestrant) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

paclitaxel injection

Breast Cancer, Lung Cancer, Ovarian

paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for intravenous use Initial U.S. Approval: 2005

paclitaxel injection is a prescription medicine used to treat some forms of: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma It is not known if TAXOL is safe or effective in children.

Facts about paclitaxel injection

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): paclitaxel injection
Dosage Forms And Strengths: For injectable suspension: white to yellow, sterile, lyophilized powder containing 100 mg of paclitaxel formulated as albumin-bound particles in single-dose vial for reconstitution.
Current indications: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import paclitaxel injection” based on the information you provide.

Pembrolizumab Injection

Kidney, Breast Cancer, Gastrointestinal, Lung Cancer, Lymphoma, Skin

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

USAGE-intravenous
MEDICINE APPROVED BY- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Initial U.S. Approval: 2014
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “pembrolizumab injection” based on the information you provide.

PERJETA (pertuzumab) injection

Breast Cancer, Solid Tumors

Brand Name: PERJETA Generic Name: (Pertuzumab)
Perjeta (Pertuzumab) is used to treat patients with HER2-positive metastatic breast cancer

PERJETA is a HER2/neu receptor antagonist indicated in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

Brand Name:	PERJETA
Generic Name:	Pertuzumab
Strength:	Injection: 420 mg/14 mL single-use vial.
Manufacturer:	Genentech
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Perjeta (Pertuzumab)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Perjeta (Pertuzumab) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Breast Cancer

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200

Access the best support services globally

LYNPARZA (olaparib) tablets, for oral use Initial U.S. Approval: 2014

margetuximab-cmkb injection for intravenous use Initial U.S. approval: 2020

Facts about margetuximab-cmkb injection

Access the best support services globally

neratinib tablets, for oral use Initial U.S. Approval: 2017

Facts about neratinib tablets

Access the best support services globally

NERLYNX (neratinib) tablets, for oral use Initial U.S. Approval: 2017

Access the best support services globally

Brand Name: ORSERDU. Generic Name: elacestrant). It is used to treat advanced or metastatic breast cancer.

paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for intravenous use Initial U.S. Approval: 2005

Facts about paclitaxel injection

Access the best support services globally

Brand Name: Keytruda. Generic Name: pembrolizumab Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

Access the best support services globally

Brand Name: PERJETA Generic Name: (Pertuzumab) Perjeta (Pertuzumab) is used to treat patients with HER2-positive metastatic breast cancer

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

margetuximab-cmkb injection
for intravenous use Initial U.S. approval: 2020

neratinib tablets,
for oral use Initial U.S. Approval: 2017

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Brand Name: PERJETA Generic Name: (Pertuzumab)
Perjeta (Pertuzumab) is used to treat patients with HER2-positive metastatic breast cancer